Heterozygote x Wild-type [or Crossing to Jcl:MCH(ICR)] Heterozygote x Wild-type [or Crossing to Jcl:MCH(ICR)] <a href='https://brc.riken.jp/mus/pcr06173'>Genotyping protocol -PCR-</a> 条件を付加する。利用者は提供承諾書を用いて、事前に寄託者の承諾を得る。<br>研究成果の公表にあたって寄託者の指定する文献を引用する。Development, 130, 1725-1734 (2003). 北里大学理学部・渡辺大介先生により育成。FVB背景のinv変異マウスをICRへ交配する事により作出（7世代以上）。 ICR,inv mutant, ICR-inv ICR,inv mutant, ICR-inv Developed by Daisuke Watanabe, School of Science, Kitasato University. The mutant mice were crossed to ICR. Necessary documents for ordering:<ol><li>Approval form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_6.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_d.docx">English</A>)</li><li>Order form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_4.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_b.docx">English</A>)</li><li>Category I MTA: MTA for distribution with RIKEN BRC (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_5.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_c.docx">English</A>)</li><li>Acceptance of responsibility for living modified organism (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_7.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_g.docx">English</A>)</li></ol> true 完全内臓逆位、多発性嚢胞腎を呈するinv変異系統。ICR背景では、FVB背景に比べ、完全内臓逆位の割合が100%から50%程度へ低下する。ホモマウスは致死。 Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from the DEPOSITOR using the Approval Form. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Development, 130, 1725-1734 (2003). 渡辺　大介 C (3-6 months) mouse tyrosinase minigene Inv mutant mice. ICR background. 50% of homozygous mice show complete situs inversus. C（3〜6か月） Daisuke WATANABE ICR;FVB-Invs<inv> ICR;FVB-Invs<inv> RBRC06173